腹膜透析患者的高血压患病率达80%以上，难治性高血压导致卒中、心血管事件发病率不断增加，是患者死亡和退出腹膜透析的主要原因。2015年国际腹膜透析协会(ISPD)关于成人腹膜透析患者心血管和代谢指南指出，持续腹膜透析患者目标血压应<140/90 mmHg，并与年龄无关。腹膜透析患者血压控制不佳的影响因素纷繁复杂，但常见原因是容量超负荷和残肾功能减退。腹膜透析患者高血压防治策略包括容量负荷的准确评估与干预、残余肾功能的有效保护、透析处方的及时调整，降压药物的正确选择以及以病人为中心的团队管理等五个方面。

Hypertension is extremely common in patients on peritoneal dialysis (PD), with a prevalence of more than 80%. Moreover, refractory hypertension accounts for the increasing incidence of stroke and cardiovascular events which are the leading causes for death and peritoneal dialysis dropout. The 2015 International Society of Peritoneal Dialysis cardiovascular and metabolic guidelines for adult peritoneal dialysis patients recommended that the target of blood pressure in continuous ambulatory PD patients should be <140 mmHg systolic and <90 mmHg diastolic, irrespective of age. There are various factors that contribute to the poor control of hypertension in PD patients, of which hypervolumia and reduced residual renal function are the most common ones. Therapeutic strategies for blood pressure management in PD patients include 5 aspects: appropriate assessment on volume status, effective protection of residual renal function, flexible adjustment of dialysis prescription, right choice of anti-hypertensive drugs, and patient-centered team management.